Trials / Not Yet Recruiting
Not Yet RecruitingNCT07030101
A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
A Phase 3 Double-blind, Multicenter, Randomized, Double-blind, Triple-dummy, Controlled Trial to Assess the Efficacy and Safety of a TCA108 in Participants ≥18 Years of Age With Uncontrolled Hypertension
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study if to evaluate the efficacy and safety of TCA108 in the treatment of hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TCA108 | TCA108 |
| DRUG | Bramicar HCT | Bramicar HCT |
| DRUG | Micardis Anlo | Micardis Anlo |
Timeline
- Start date
- 2026-11-01
- Primary completion
- 2029-05-01
- Completion
- 2029-11-01
- First posted
- 2025-06-19
- Last updated
- 2025-11-24
Source: ClinicalTrials.gov record NCT07030101. Inclusion in this directory is not an endorsement.